Liu, T., Qin, Y., Li, J., Xu, R., Xu, J., Yang, S., . . . Shen, L. (2019). Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: A subpopulation analysis of the JACOB trial. Cancer Commun (Lond).
Style de citation ChicagoLiu, Tianshu, et al. "Pertuzumab in Combination With Trastuzumab and Chemotherapy for Chinese Patients With HER2-positive Metastatic Gastric or Gastroesophageal Junction Cancer: A Subpopulation Analysis of the JACOB Trial." Cancer Commun (Lond) 2019.
Style de citation MLALiu, Tianshu, et al. "Pertuzumab in Combination With Trastuzumab and Chemotherapy for Chinese Patients With HER2-positive Metastatic Gastric or Gastroesophageal Junction Cancer: A Subpopulation Analysis of the JACOB Trial." Cancer Commun (Lond) 2019.